- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Pricing
- SKY Learn
- Mutual Funds
- Margin Trading
- Financial Planning
- Personal Finance
- Share Trading
- IPO
- Derivatives
- Currencies
- Intraday Trading
- Trading Strategies
- Demat Account
- Commodity
- ETF
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Alembic Pharma Share Price
Alembic Pharmaceuticals Ltd.
₹675.60
12.35(1.86%)
Invest in APLLTD with up to 2.50x margin.
Trade with MTF1st Apr 2026 | 2:50 PM
NSE : APLLTD
Open Free Demat Account
Alembic Pharma Performance
Price Movement
₹675.60
₹665.25
₹681.45
↘ Today's Low↗ Today's High
1 Year Performance
₹675.60
₹675.00
₹1107.90
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹681.45
Low₹665.25
Open at₹668.95
Prev Close₹663.25
Volumes45.18 K
Avg Price₹674.90
Lower Circuit₹530.60
Upper Circuit₹795.90
Historical Performance
3M High₹851.00
3M Low₹635.80
1 Yr High₹1,107.90
1 Yr Low₹635.80
3 Yr High₹1,303.90
3 Yr Low₹471.00
5 Yr High₹1,303.90
5 Yr Low₹462.30
Alembic Pharma Fundamentals
Market Cap
High in industry
13,037 Cr.
PE Ratio (TTM)
Above industry Median
20.70
Dividend Yield
High in industry
1.70
Net Profit TTM
4.0% incr over last year
628.95
Net Profit Growth
4.0% incr over last year
628.95
PEG Ratio
High in industry
5.20
ROE
12% decr over last year
11.23
Operating Revenue TTM
7,266.82
Operating Revenue Growth
13.2% incr over last year
Book Value
Above industry Median
2.40
MFI
MFI is mid-range
33.79
RSI
RSI is mid-range
38.45
EPS (TTM)
29.68
Debt to Equity
0.23
Face Value
2
Operating Profit Margin Qtr.
15.02
Operating Profit Qtr.
293.49
Net Profit Qtr.
132.97
Operating Revenue Qtr.
1,876.31
PB Ratio
2.40
Alembic Pharma Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 1,642.24 | 1,796.24 | 1,494.17 | 1,570.64 | 1,406.09 |
| Operating Expense | 1,370.64 | 1,492.93 | 1,280.43 | 1,399.98 | 1,226.26 |
| Operating Profit | 271.60 | 303.31 | 213.74 | 170.66 | 179.83 |
| Depreciation | 79.67 | 75.64 | 73.37 | 68.60 | 69.69 |
| Interest | 21.65 | 22.81 | 22.64 | 23.71 | 21.79 |
| Tax | 24.31 | 36.99 | 22 | 16.22 | 18 |
| Net Profit | 114.47 | 179.36 | 103.52 | 75.34 | 85.81 |
Alembic Pharma Technicals
Alembic Pharmaceuticals Ltd. EMA & SMA
₹675.60
2.05 (0.30%)
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
Day EMA5 ₹671.4
Day EMA10 ₹675.9
Day EMA12 ₹678.7
Day EMA20 ₹691.6
Day EMA26 ₹701.4
Day EMA50 ₹736.1
Day EMA100 ₹788.7
Day EMA200 ₹846.8
Alembic Pharma Support and Resistance
Resistance
First Resistance₹672.95
Second Resistance₹682.65
Third Resistance₹691.30
Support
First Support₹654.60
Second Support₹645.95
Third Support₹636.25
Technical Indicators
Day RSI38.45
Day MFI33.79
Day ADX33.19
Day Commodity Channel Index-88.90
William-69.35
Day MACD-22.70
Day MACD Signal Line-24.69
Day ATR24.93
Day ROC125-28.06
Day ROC21-10.36
Alembic Pharma Shareholding Pattern
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 69.6 | 69.6 | 69.7 | 69.7 | 69.7 | 69.7 |
| FII | 3.9 | 4.2 | 3.9 | 4 | 4 | 4.2 |
| DII | 16.1 | 16 | 16.5 | 16.4 | 16.3 | 16.2 |
| Public | 10.4 | 10.2 | 10 | 9.9 | 9.9 | 9.8 |
Alembic Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 38.66 K | 85.22 K | 45.36% |
| Week | 1.99 L | 3.17 L | 62.60% |
| 1 Month | 65.49 K | 1.16 L | 56.60% |
| 6 Month | 42.27 K | 1.27 L | 33.32% |
Alembic Pharma SWOT Analysis
Strengths6
Weakness13
Opportunity4
Threats3
Benjamin Graham Value Screen
Dividend yield greater than sector dividend yield
Effectively using its capital to generate profit - RoCE improving in last 2 years
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Alembic Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 29 Jul, 2025 | 11 | FINAL | 29 Jul, 2025 | Equity Share |
| 15 Jul, 2024 | 11 | FINAL | 15 Jul, 2024 | Equity Share |
| 28 Jul, 2023 | 8 | FINAL | 28 Jul, 2023 | Equity Share |
| 17 Aug, 2022 | 10 | INTERIM | 18 Aug, 2022 | Equity Share |
| 19 Jul, 2021 | 14 | FINAL | Equity Share | |
| 16 Mar, 2020 | 7 | INTERIM | 17 Mar, 2020 | Equity Share |
| 16 Mar, 2020 | 3 | SPECIAL | 17 Mar, 2020 | Equity Share |
| 18 Jul, 2019 | 5.5 | FINAL | Equity Share | |
| 18 Jul, 2018 | 4 | FINAL | Equity Share | |
| 11 Jul, 2017 | 4 | FINAL | Equity Share |
Alembic Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,546.20 | ₹614.65 | ₹783.65 | ₹4,812.80 | ₹589.70 | ₹1,463.50 |
| % Change | -0.63% | 3.73% | 1.40% | 0.29% | 9.26% | -0.67% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹1,348.51 | ₹724.81 | ₹1,419.33 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹293.49 | ₹204.17 | ₹20.10 |
| PE TTM | - | - | 61.70 | 27.10 | 32.90 | 840.10 |
| 1 Year Return | 46.52 | -0.08 | 59.34 | -6.76 | 23.63 | -15.92 |
| ROCE | 30.24 | 34.78 | 34.76 | - | 35.59 | 3.26 |
Similar Stocks
SANOFICONR
Sanofi Consumer Healthcare India Ltd.
₹ 4512.30
+4.98%
AKUMS
Akums Drugs & Pharmaceuticals Ltd.
₹ 495.05
+6.21%
BLUEJET
Blue Jet Healthcare Ltd
₹ 347.70
+6.25%
CONCORDBIO
Concord Biotech Ltd.
₹ 1019.70
+0.13%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 627.85
+6.06%
PPLPHARMA
Piramal Pharma Ltd.
₹ 141.64
+3.74%
ACUTAAS
Acutaas Chemicals Ltd.
₹ 2304.10
-9.95%
ALIVUS
Alivus Life Sciences Ltd.
₹ 991.55
+1.94%
COHANCE
Cohance Lifesciences Ltd.
₹ 308.80
+2.44%
ERIS
Eris Lifesciences Ltd.
₹ 1301.00
+0.29%
SYNGENE
Syngene International Ltd.
₹ 394.70
+1.23%
STAR
Strides Pharma Science Ltd.
₹ 961.85
+2.57%
GRANULES
Granules India Ltd.
₹ 630.00
+1.55%
WOCKPHARMA
Wockhardt Ltd.
₹ 1263.40
+7.46%
FDC
FDC Ltd.
₹ 327.15
+1.88%
SHILPAMED
Shilpa Medicare Ltd.
₹ 371.80
+6.56%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 816.10
-0.04%
NATCOPHARM
Natco Pharma Ltd.
₹ 1000.60
+2.71%
CAPLIPOINT
Caplin Point Laboratories Ltd.
₹ 1568.70
+4.25%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 12570.00
+4.51%
MARKSANS
Marksans Pharma Ltd.
₹ 166.49
+6.12%
SANOFI
Sanofi India Ltd.
₹ 3247.50
+1.18%
FAQ's on APLLTD
What is the current share price of Alembic Pharmaceuticals Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Alembic Pharmaceuticals Ltd. is ₹ 675.6 on the NSE and ₹ 675.75 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Alembic Pharmaceuticals Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Alembic Pharmaceuticals Ltd. is approximately ₹ 13037 Cr.
What are the PE and PB ratios for Alembic Pharmaceuticals Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Alembic Pharmaceuticals Ltd. is 20.7, and the Price-to-Book (PB) ratio is 2.4.
What is the 52-Week High and Low for Alembic Pharmaceuticals Ltd.?
Over the past 52 weeks, the highest price reached by Alembic Pharmaceuticals Ltd. shares was ₹ 1107.9, and the lowest price was ₹ 635.8.
What is the current dividend yield for Alembic Pharmaceuticals Ltd.?
As of 6 June 2025, the dividend yield for Alembic Pharmaceuticals Ltd. is 1.7%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of Alembic Pharmaceuticals Ltd.?
Significant shareholdings in Alembic Pharmaceuticals Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Public
- Mutual Funds
- Other Institutions
- FII
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Alembic Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Alembic Pharmaceuticals Ltd. is often compared with other major players such as
Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.
What is the latest dividend information for Alembic Pharmaceuticals Ltd.?
Alembic Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 11 per share for the financial period ending 2025. The record date was set as 2025-07-29, and the payment was/is scheduled around 2025-07-29. For the most current dividend announcements, refer to official company filings.
What is the shareholding pattern for Alembic Pharmaceuticals Ltd.?
As per the filings for the quarter ending Dec 2025, the approximate shareholding pattern for Alembic Pharmaceuticals Ltd. is:
- Promoters: 69.7%
- Domestic Institutional Investors (DII): 16.2%
- Foreign Institutional Investors (FII): 4.2%
- Others (including Public): 0.1%
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy